Tag: Dr. Richard Baum

SNMMI logo 3

SNMMI Patient Education Day – Hybrid (In-Person and Virtual)

May 25, 2022

The Society of Nuclear Medicine and Molecular Imaging will offer a special Patient Education Day on Sunday, June 12 as part of its 2022 Annual Meeting. This free event offers patients and caregivers a unique opportunity to learn about the role of nuclear…

READ MORE
thomas odorisio md theranostics congress march 2015

15 Videos from the 3rd Theranostics World Congress

May 14, 2015

The 3rd Theranostics World Congress featured a patient education day on Saturday, March 14, made possible with support from the Carcinoid Cancer Foundation and the Caring for Carcinoid Foundation. The NorCal CarciNET Community provided funding to…

READ MORE
josh mailman 5

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging 2014 Meeting

April 25, 2014

Josh Mailman, President of the NorCal CarciNET Community  and Chair of the Patient Advocacy Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June…

READ MORE
society of nuclear medicine patient program june 2013

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program

May 22, 2013

Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day …

READ MORE
jan naritomi hart

10 Highlights of the Year 2011 for the Carcinoid and Neuroendocrine Tumor Community

December 15, 2011

As the Carcinoid Cancer Foundation looks back on the year 2011, there were many significant events and advances for the carcinoid and neuroendocrine tumor (NET) community.  Here are 10 of the year’s important stories:

1)     The FDA approved the first…

READ MORE
Multidisciplinary Team at Bad Berka

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

April 5, 2011

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …

READ MORE
staff sergeant daniel barber helicopter

A Carcinoid Soldier’s Survivor Story

October 1, 2010

When Staff Sergeant Daniel Barber of D Company 1-106th AVN in the Missouri National Guard was first diagnosed with carcinoid cancer in 2009 he experienced feelings of shock, despair, anger, fear and frustration.  But he was also relieved because he knew…

READ MORE